Division on Substance Abuse, New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, USA.
Am J Addict. 2011 Sep-Oct;20(5):441-6. doi: 10.1111/j.1521-0391.2011.00148.x. Epub 2011 Jul 11.
Depressive symptoms often coexist with substance use disorders (SUDs). The DSM-IV has identified two distinct categories for depression coexisting with SUDs-independent depression and substance-induced depression. While this distinction has important therapeutic and prognostic implications, it remains difficult to make in clinical practice; the differentiation is often guided by chronological and symptom severity criteria that patients may be unable to precisely provide. Furthermore, it is unclear whether the various substances commonly abused-cannabis, cocaine, and opioids-are equally associated with the two types of depression. Predictors, associations, and other markers may be helpful in guiding the diagnostic process. We, therefore, examined the differences between cannabis-, cocaine-, and opioid-dependent individuals contending with independent depression and those contending with substance-induced depression in regard to several variables, hypothesizing that independent depression is more commonly found in females, and that it is associated with higher symptom severity and psychiatric comorbidity. Cocaine-, cannabis-, and/or opioid-dependent, treatment-seeking individuals underwent a structured clinical interview for DSM-IV-TR disorders after providing consent at our clinical research site; those with co-existing primary depression or substance-induced depression diagnoses were provided with further questionnaires and were entered into this analysis (n= 242). Pair-wise comparisons were conducted between the groups classified as independent versus substance-induced depression with 2-by-2 tables and chi-square tests for dichotomous independent variables, and t-tests for continuous variables. Binomial logistic regression was performed in order to ascertain which of the variables were significant predictors. Women were more likely than men to have independent depression (p< .005). Cannabis dependence was highly associated with independent depression (p< .001), while cocaine dependence was highly associated with substance-induced depression (p< .05). Independent depression was associated with higher Hamilton depression scale scores (16 vs. 10, p< .005), and was more highly associated with the comorbid diagnosis of posttraumatic stress disorder (p< .05). Cannabis dependence (p< .001) and female gender (p< .05) were highly significant predictors of major depression specifically. Gender, cannabis dependence, psychiatric severity, and psychiatric comorbidity have variable, statistically significant associations with independent and substance-induced depression, and may be helpful in guiding the diagnostic process.
抑郁症状常与物质使用障碍(SUD)共存。DSM-IV 确定了两种不同的类别,用于同时存在 SUD 和抑郁的情况:独立型抑郁和物质诱发型抑郁。虽然这种区分具有重要的治疗和预后意义,但在临床实践中仍难以确定;这种区分通常是根据患者可能无法准确提供的时间和症状严重程度标准来指导的。此外,尚不清楚常用的各种滥用物质(大麻、可卡因和阿片类药物)是否与这两种类型的抑郁同样相关。预测因素、关联和其他标志物可能有助于指导诊断过程。因此,我们研究了在几种变量方面,与独立型抑郁和物质诱发型抑郁作斗争的大麻、可卡因和阿片类药物依赖者之间的差异,假设独立型抑郁在女性中更为常见,并且与更高的症状严重程度和精神共病有关。在我们的临床研究点同意后,可卡因、大麻和/或阿片类药物依赖的寻求治疗的个体接受了 DSM-IV-TR 障碍的结构化临床访谈;那些有共存原发性抑郁或物质诱发型抑郁诊断的个体提供了进一步的问卷,并被纳入了这项分析(n=242)。通过 2-by-2 表和二项式独立变量的卡方检验,以及连续变量的 t 检验,对被归类为独立型与物质诱发型抑郁的两组进行了两两比较。进行二项逻辑回归以确定哪些变量是显著的预测因素。女性比男性更有可能患有独立型抑郁(p<.005)。大麻依赖与独立型抑郁高度相关(p<.001),而可卡因依赖与物质诱发型抑郁高度相关(p<.05)。独立型抑郁与更高的汉密尔顿抑郁量表评分相关(16 分与 10 分,p<.005),并且与创伤后应激障碍的共病诊断高度相关(p<.05)。大麻依赖(p<.001)和女性性别(p<.05)是重度抑郁的高度显著预测因素。性别、大麻依赖、精神疾病严重程度和精神共病与独立型和物质诱发型抑郁有不同的、有统计学意义的关联,可能有助于指导诊断过程。